You just read:

PharmaEngine Announces Onivyde(R) Receives European Marketing Authorization for the Treatment of Metastatic Adenocarcinoma of the Pancreas Following Gemcitabine based Therapy

News provided by

PharmaEngine, Inc.

18 Oct, 2016, 07:47 ET